Inter J Stomatol ›› 2016, Vol. 43 ›› Issue (3): 268-272.doi: 10.7518/gjkq.2016.03.004
Previous Articles Next Articles
Wu Dong, Bao Guanghui
CLC Number:
[1] Roskoski R Jr. ERK1/2 MAP kinases: structure, function, and regulation[J]. Pharmacol Res, 2012, 66(2):105-143. [2] Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer[J]. Cell Cycle, 2009, 8(8):1168-1175. [3] Xu DJ, Zhao YZ, Wang J, et al. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells[J]. BMB Rep, 2012, 45(4):247-252. [4] Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament[J]. Lancet, 2004, 364(9429):149-155. [5] Wang L, Dormer NH, Bonewald LF, et al. Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds[J]. Tissue Eng Part A, 2010, 16(6):1937-1948. [6] Dai J, Wang J, Lu J, et al. The effect of co-culturing costal chondrocytes and dental pulp stem cells combined with exogenous FGF9 protein on chondrogenesis and ossification in engineered cartilage[J]. Biomaterials, 2012, 33(31):7699-7711. [7] Twigg SR, Vorgia E, McGowan SJ, et al. Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis[J]. Nat Genet, 2013, 45(3):308-313. [8] Bai B, He J, Li YS, et al. Activation of the ERK1/2 signaling pathway during the osteogenic differentiation of mesenchymal stem cells cultured on substrates modified with various chemical groups[J]. Biomed Res Int, 2013, 2013:361906. [9] Xu L, Meng F, Ni M, et al. N-cadherin regulates osteogenesis and migration of bone marrow-derived mesenchymal stem cells[J]. Mol Biol Rep, 2013, 40(3):2533-2539. [10] Miraoui H, Oudina K, Petite H, et al. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling[J]. J Biol Chem, 2009, 284(8):4897-4904. [11] De Rocca Serra-Nédélec A, Edouard T, Tréguer K, et al. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature[J]. Proc Natl Acad Sci USA, 2012, 109(11):4257-4262. [12] Rajshankar D, McCulloch CA, Tenenbaum HC, et al. Osteogenic inhibition by rat periodontal ligament cells: modulation of bone morphogenic protein-7 activity in vivo[J]. Cell Tissue Res, 1998, 294(3):475-483. [13] Matsuda N, Kumar NM, Ramakrishnan PR, et al. Evidence for up-regulation of epidermal growthfactor receptors on rat periodontal ligament fibroblastic cells associated with stabilization of phenotype in vivo[J]. Arch Oral Biol, 1993, 38(7):559-569. [14] Tang X, Meng H, Han J, et al. Up-regulation of estrogen receptor-beta expression during osteogenic differentiation of human periodontal ligament cells[J]. J Periodont Res, 2008, 43(3):311-321. [15] James AW. Review of Signaling pathways governing MSC osteogenic and adipogenic differentiation[J]. Scientifica: Cairo, 2013, 2013:684736. |